Weekly shot shows promise for double trouble of diabetes and weight
NCT ID NCT05537233
Summary
This study tested whether adding a weekly injection called semaglutide could help adults who have both type 1 diabetes and obesity. For 26 weeks, 115 participants using automated insulin pumps received either the real injection or a placebo (dummy shot). Researchers measured if the treatment helped people spend more time in a healthy blood sugar range while also losing weight.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barbara Davis Center for Diabetes
Aurora, Colorado, 80045, United States
-
Harold Schnitzer Diabetes Health Center
Portland, Oregon, 97239, United States
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
-
Iowa Diabetes Research Center
West Des Moines, Iowa, 50265, United States
Conditions
Explore the condition pages connected to this study.